Loading viewer...
investor_presentation
Format: PDF investor_presentation
Camallergy is a clinical-stage biotech company developing peanut oral immunotherapy (OIT) treatments. The presentation outlines the company's leadership team, clinical operations, and regulatory pathway, featuring executives with extensive experience in immunology, allergy treatment, and pharmaceutical commercialization.
investor_presentation
26 Pages
Kingfisher
Phibro Animal Health Investor Presentation — May 2022
investor_presentationinvestor_presentation
11 Pages
Phibro Animal Health Corporation
Gehlen Bräutigam Value HI Fund 2023 Marketing Information
investor_presentationinvestor_presentation
44 Pages
Gehlen Bräutigam Capital GmbH
Teva Pharmaceutical Industries Investor Presentation — November 2017
investor_presentationinvestor_presentation
28 Pages
Teva Pharmaceutical Industries